Outlook Therapeutics, Inc. (OTLK) earnings
OTLK earnings moved a median of -0.35% by the close. Quarterly and annual OTLK reports and results, each read against the price at its own news timestamp. Back to the OTLK overview →
15 measured OTLK earnings events.
Where these OTLK earnings landedvs 15 measured OTLK earnings reactions
| Middle 50% of OTLK earnings reactions | -4.78% to +3.01% |
|---|---|
| Median reaction (to close) | -0.35% |
| Measured reactions | 15 |
Point-in-time · zero look-ahead
Half of the 15 OTLK earnings events with a measured close landed between -4.78% and +3.01%; 40% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Outlook Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.41% | -2.50% | |
| Form NT 10-Q Outlook Therapeutics, For: Jun 30 | SEC filing · Form NT | +2.50% | +4.14% | |
| Form 10-Q Outlook Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -1.48% | -0.35% | |
| Form 10-Q Outlook Therapeutics, For: Dec 31 | SEC filing · Form 10-Q | -3.87% | -3.98% | |
| Form 10-K Outlook Therapeutics, For: Sep 30 | SEC filing · Form 10-K | -0.74% | -9.36% | |
| Form 10-Q Outlook Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -5.60% | -6.40% | |
| Form 10-Q Outlook Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -2.35% | +2.94% | |
| Form 10-Q Outlook Therapeutics, For: Dec 31 | SEC filing · Form 10-Q | -3.19% | -9.04% | |
| Form 10-K/A Outlook Therapeutics, For: Sep 30 | SEC filing · Form 10-K | -0.49% | -1.49% | |
| Form 10-K Outlook Therapeutics, For: Sep 30 | SEC filing · Form 10-K | +1.49% | -5.58% | |
| Form 10-Q Outlook Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.34% | +3.09% | |
| Form 10-Q Outlook Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +2.66% | |
| Form 10-Q Outlook Therapeutics, For: Dec 31 | SEC filing · Form 10-Q | +3.94% | +7.73% | |
| Form 10-K/A Outlook Therapeutics, For: Sep 30 | SEC filing · Form 10-K | -4.71% | -0.21% | |
| Form 10-K Outlook Therapeutics, For: Sep 30 | SEC filing · Form 10-K | +4.63% | +3.72% |
Keep exploring
More OTLK: analyst actions → · SEC filings → · OTLK overview →